Market Overview

According to fortune business insights, the global exosome research market size was valued at USD 159.1 million in 2025. The market is projected to grow from USD 177.5 million in 2026 to USD 458.8 million by 2034, exhibiting a CAGR of 12.61% during the forecast period. North America dominated the global exosome research market with a market share of 43.37% in 2025.

The analysis shows that the market is witnessing strong growth driven by the rising global cancer burden, a strong emphasis on biomarker discovery, and a shift toward personalized medicine. Key industry players such as Thermo Fisher Scientific Inc. and QIAGEN are shaping the market through innovative product offerings and strategic initiatives.

Major Players Profiled in the Market Report:

• Thermo Fisher Scientific Inc. (U.S.)
• QIAGEN (Germany)
• Lonza (Switzerland)
• System Biosciences, LLC. (U.S.)
• Danaher (U.S.)
• FUJIFILM Corporation (Japan)
• IZON Science LTD (New Zealand)
• STEMCELL Technologies (Canada)
• RoosterBio, Inc. (U.S.)
• Spectris (U.S.)

Segments

Rising Demand for Reagents and Kits to Propel Products Segment Growth

Based on offering, the market is divided into products and services. The product segment is expected to capture the largest market share due to the high usage of reagents and kits in research applications.

Importance of Isolation in All Applications to Drive Segment Growth

By workflow, the market is segmented into isolation & purification, characterization, profiling, and others. The isolation & purification segment holds the largest market share, projected at 36.0% in 2026, as it is the essential first step for all downstream exosome research activities.

High Focus on Biomarker Discovery to Propel Segment Expansion